EXPERT SPEAKERS Bryan Allinson Co-Founder & Chief Executive Officer Vanquish Bio Chris Paradise Vice President - Research & Development Rion Christopher Locher Chief Executive Officer Versatope Therapeutics Clayton Deighan Sales & Applications Manager Nano FCM Davide Zocco Head of Exosomes Development and Site Head Lonza Doug Arm Chief Operating Officer EV Therapeutics Fatah Kashanchi Professor of Virology George Mason University Gianluca Roma CEO EV Therapeutics Hans Hofland Senior Vice President - Preclinical Development Turn Biotechnologies Ina Sarel Head of Chemistry, Manufacturing, Controls, Quality & Regulatory NurExone Biologic Jacki Kornbluth Co-Founder & Chair for Scientific Advisory Board Vanquish Bio Jahan Jowharchi Chief Technical Operations Rion Joseph Barendt Senior Director of Business Development Daicel Life Sciences Kenichi Tamura Head of CMC development Exorphia Kristin Luther VP of CMC AGS Therapeutics Kuldeep Neote CEO Diadem Biotherapeutics Mafalda Cacciottolo Director - Exosome Research Capricor Therapeutics Marcos Langtry Cgt Director, Commercial Development Lonza Mickey Pentecost Chief Scientific Officer & Board Director Diadem Biotherapeutics Nicolas Rousseau Co-Founder & Chief Operating Officer EVerZom Phong Le Professor of Microbiology & Immunology and Cancer Biology Loyola University Chicago Pranav Sharma Founder & Chief Executive Officer Xosomix R. Kenneth Marcus Professor of Chemistry Clemson University Sandrine Mores Chief Operation Officer EXO Biologics Shelley Hartman Chief Executive Officer Aegle Therapeutics Steven Jay Associate Professor University of Maryland Steven Stice Co-Founder & Chief Scientific Officer ArunA Bio Timothy Moseley Chief Scientific Officer Direct Biologics Xenia Sango Chief Executive Officer & Managing Director VivaZome Therapeutics Xinjun He Chief Scientific Officer & Senior Vice President VesiCURE Therapeutics PARTNERSHIP OPPORTUNITIES OFFICIAL BROCHURE